Aura Biosciences Inc.

NASDAQ: AURA · Real-Time Price · USD
6.73
-0.27 (-3.86%)
At close: Aug 15, 2025, 3:59 PM
6.85
1.78%
After-hours: Aug 15, 2025, 05:02 PM EDT

Aura Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-27.02M -27.48M -25.83M -21.04M -20.34M -19.71M -22.13M -18.51M -18.3M -17.47M -16.56M -15.9M -13.47M -12.84M -11.63M -8.84M -8.85M -5.93M
Depreciation & Amortization
286K 291K 291K 313K 313K 306K 324K 343K 300K 328K 323K 302K 296K 256K 230K 216K 200K 185K
Stock-Based Compensation
3.83M 3.51M 2.94M 2.75M 3.13M 2.91M 2.6M 2.33M 1.93M 1.91M 1.81M 1.72M 1.29M 1.59M 1.3M 554K 271K 185K
Other Working Capital
n/a n/a -1.25M 2.69M 2.27M -6.83M 1.58M -77K 2.4M 1.88M -4.79M 2.63M 1.91M -3.49M -2.16M 149K 914K -272K
Other Non-Cash Items
2.13M n/a -404K -672K -955K 2.34M 2.58M 453K 557K -892K 179K -341K 5K 35K -24.09M 2K 6K -4K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -2.79M -820K -1.03M n/a n/a n/a n/a n/a 24.11M -52K 52K -4K
Change in Working Capital
n/a n/a -942K 3.38M 1.73M -6.8M 2.03M 808K 1.89M -295K -3.77M 3.46M 1.46M -4.25M -2M -572K 1.83M 428K
Operating Cash Flow
-20.77M -23.36M -23.95M -15.27M -16.13M -24.45M -17.39M -15.4M -14.64M -16.41M -18.01M -10.76M -10.63M -15.2M -12.09M -8.69M -6.5M -5.14M
Capital Expenditures
-39K -187K -299K -341K -525K -88K -317K -90K -193K -109K -358K -63K -74K -599K -819K -573K -662K -71K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 89.8K n/a n/a 66.77K 16.52K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-9.98M n/a -5K -20M -9.9M -29.2M -144.8M n/a n/a -88.85M -48.52M n/a -46.37M -24.9M n/a n/a n/a n/a
Sales Maturities Of Investments
30M 30M 30M 30.23M 30.27M 38.69M 55M 21.72M 21.6M 22.08M 32M 18.01M 3M n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 9.48M -89.8K 21.72K 21.6K -66.77K -16.52K 18.01K -43.37M -24.9M n/a n/a n/a n/a
Investing Cash Flow
19.98M 29.81M 29.7M 9.89M 19.84M 9.4M -90.12M 21.63M 21.41M -66.88M -16.88M 17.95M -43.44M -25.5M -819K -573K -662K -71K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
69.93M 96K 543K 716K 83K 253K 92.98M 274K 2.48M 201K 8.55M 104K 309K 17K 80.14M -1.12M -256K 256K
Financial Cash Flow
69.93M 96K 543K 716K 83K 253K 92.98M 1.63M 2.48M 201K 95.2M 104K 309K 17K 80.14M -1.12M -256K 87.49M
Net Cash Flow
69.14M 6.53M 6.29M -4.67M 3.8M -14.8M -14.52M 7.85M 9.24M -83.09M 60.31M 7.29M -53.76M -40.68M 67.24M -10.38M -7.42M 82.28M
Free Cash Flow
-20.81M -23.54M -24.25M -15.61M -16.65M -24.54M -17.7M -15.49M -14.84M -16.52M -18.37M -10.82M -10.7M -15.8M -12.9M -9.26M -7.16M -5.21M